Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Nitinol Stent Implantation in the Superficial Femoral Artery and Proximal Popliteal Artery: Twelve-Month Results From the Complete SE Multicenter Trial

John R. Laird , MD; Ash Jain , MD; Thomas Zeller , MD; Robert Feldman , MD; Dierk Scheinert , MD; Jeffrey J. Popma , MD; Ehrin J. Armstrong , MD; and Michael R. Jaff , DO

Purpose: To determine the safety and efficacy of a new-generation nitinol stent with enhanced flexibility in arterial lesions in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Corrosion Resistance, Surface Evaluation, and Geometric Design Comparison of Five Self-Expanding Nitinol Stents Used in Clinical Practice

Jasper W. Morrison , MBBS; Matthew H. Pelletier , PhD; Alain Rives , PhD; William R. Walsh , PhD; Jia-Lin Yang , PhD; and Ramon L. Varcoe , MBBS, MS, FRACS

Purpose: To investigate the corrosion resistance properties of 5 commercially available nitinol stents used to treat peripheral artery disease and compare their surface quality, elemental composition, and geometrical design.

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Propensity Score Analysis of Clinical Outcome After Bypass Surgery vs. Endovascular Therapy for Infrainguinal Artery Disease in Patients With Critical Limb Ischemia

Yoshimitsu Soga , MD; Shinsuke Mii , MD; Osamu Iida , MD; Jin Okazaki , MD; Sosei Kuma , MD; Keisuke Hirano , MD; Kenji Suzuki , MD; Daizo Kawasaki , MD; Terutoshi Yamaoka , MD; Daisuke Kamoi , MD; and Yoshiaki Shintani , MD

Purpose: To compare endovascular therapy (EVT) outcomes to those of bypass surgery (BSG) for infrainguinal artery disease in patients with critical limb ischemia (CLI).

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. Endovascular Treatment of Infrainguinal Chronic Total Occlusions Using the TruePath Device: Features, Handling, and 6-Month Outcomes

Subhash Banerjee , MD; Karan Sarode , MA; Thomas Das , BA; Omar Hadidi , MD; Rahul Thomas , MD; Ariel Vinas , MD; Puja Garg , PhD; Atif Mohammad , MD; Mirza S. Baig , MD; Nicolas W. Shammas , MD; and Emmanouil S. Brilakis , MD, PhD

Purpose: To report experience with a recently approved peripheral chronic total occlusion (CTO) crossing device in the superficial femoral (SFA), popliteal, and below-the-knee (BTK) arteries.

01 abril 2014

JOURNAL OF ENDOVASCULAR THERAPY. A Sheathless Retrograde Approach Via the Popliteal Artery Is Useful and Safe for Treating Chronic Total Occlusions in the Superficial Femoral Artery

Takahiro Tokuda , MD; Keisuke Hirano , MD; Toshiya Muramatsu , MD; Reiko Tsukahara , MD; and Masatsugu Nakano , MD

Purpose: To compare the safety and success of a retrograde approach using a microcatheter vs. a sheath in the treatment of superficial femoral artery (SFA) chronic total occlusions (CTOs).

01 mayo 2014

JOURNAL OF VASCULAR SURGERY. Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia

Gagan D. Singh, MD , Ehrin J. Armstrong, MD, MSc , Khung-Keong Yeo, MBBS , Satinder Singh, MD , Gregory G. Westin, BA , William C. Pevec, MD , David L. Dawson, MD , John R. Laird, MD

Background: Endovascular therapies are increasingly used for treatment of critical limb ischemia (CLI). Infrapopliteal (IP) occlusions are common in CLI, and successful limb salvage may require restoration of arterial flow in the distribution of a chronically occluded vessel. We sought to describe the procedural characteristics and outcomes of patients with IP occlusions who underwent endovascular intervention for treatment of CLI.

01 mayo 2014

JOURNAL OF VASCULAR SURGERY. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial)

Peter R. Nelson, MD, MS, Zvonimir Kracjer, MD , Nikhil Kansal, MD , Vikram Rao, MD , Christian Bianchi, MD , Homayoun Hashemi, MD , Paul Jones, MD , J. Michael Bacharach, MD

Objective: The first multicenter randomized controlled trial was designed and conducted to assess the safety and effectiveness of totally percutaneous endovascular aortic aneurysm repair (PEVAR) with use of a 21F endovascular stent graft system and either an 8F or 10F suture-mediated closure system (the PEVAR trial, NCT01070069). A noninferiority trial design was chosen to compare percutaneous access with standard open femoral exposure.

01 mayo 2014

JOURNAL OF VASCULAR SURGERY. Relative importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in men and women

Ruby C. Lo, MD , Bing Lu, MD, PhD , Margriet T.M. Fokkema, MD , Mark Conrad, MD , Virendra I. Patel, MD , Mark Fillinger, MD , Robina Matyal, MD , Marc L. Schermerhorn, MDemail on behalf of the Vascular Study Group of New England,

Objective: Women have been shown to have up to a fourfold higher risk of abdominal aortic aneurysm (AAA) rupture at any given aneurysm diameter compared with men, leading to recommendations to offer repair to women at lower diameter thresholds. Although this higher risk of rupture may simply reflect greater relative aortic dilatation in women who have smaller aortas to begin with, this has never been quantified. Our objective was therefore to quantify the relationship between rupture and aneurysm diameter relative to body size and determine whether a differential association between aneurysm diameter, body size, and rupture risk exists for men and women.

01 mayo 2014

JOURNAL OF VASCULAR SURGERY. Comparison of thoracic aortic diameter changes after endograft placement in patients with traumatic and aneurysmal disease

Hillary B. Alberta, MSPP, Jessica L. Secor, MD , Taylor C. Smits, BS , Mark A. Farber, MD , William D. Jordan, MD , Ali Azizzadeh, MD , Joshua D. Rovin, MD , Jon S. Matsumura, MD

Objective: The purpose of this study was to evaluate acute changes in aortic size before and after endograft placement for traumatic injury and aneurysmal disease. We hypothesize that there are inherent differences between trauma and aneurysm populations undergoing thoracic endovascular aortic repair (TEVAR) and that these factors may affect device choice and sizing for each group.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.